可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Katz SD, Hryniewicz K, Hriljac I, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure[J]. Circulation, 2005, 111(3):310-314.
[2] Penna C, Rastaldo R, Mancardio D, et al. Effect of endothelins on the cardiovascular system[J]. J Cardiovasc Med(Hagerstown), 2006, 7(9):645-652.
[3] Widlansky ME, Gokcel N, Keaney JF, et al. The clinical implications of endothelial dysfunction[J]. J Am Coll Caidiol, 2003, 42(7):1149-1160.
[4] Brunner H, Cockcroft JR, Deanfield J, et al. Endothelial function and dysfunction. Part Ⅱ: Association with cardiovascular risk factors and disease. A statement by the Working Group on Endothelins and Endothelial Factors of European Society of Hypertens[J]. J Hypertens, 2005, 23(2):233-246.
[5] Chong AY, Blann AD, Patel J, et al. Endothelial dysfunction and damage in congestive heart failure relation of flow-mediated dilation to circulating endothelial cells,Plasma indexes of endothelial damage, and brain natrinretic peptide[J]. Circulation, 2004, 110(13):1794-1798.
[6] Miakin AJ, Blann AD, Chung NA, et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor[J]. Eur Heart J, 2004, 25(5):371-376.
[7] Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force[ J]. J Am Coll Cardio1, 2002, 39(2):257-265.
[8] Kjaer A, Meyer C, Nielsen FS, et al. Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardialperfusion in diabetes[J]. J Nucl Med, 2003 ,44(1):19-23.
[9] 何友作,李秀华,李春勇,等. 充血性心力衰竭患者肱动脉流量介导性舒张功能异常及参麦液的治疗作用[J]. 心脏杂志, 2004, 16(2):137-139.
[10]Heitzer T, Baldus S, von Kodolitsch Y, et al. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure[J]. Arterioscler Thromb Vasc Biol, 2005, 25(6):1174-1179.
[11]孙大勇,朱平先,黎明,等. 老年慢性心力衰竭患者血管内皮功能的变化及临床意义[J]. 实用临床医学, 2007, 8 (6):7-9.
[12]Meyer B, Mortl D, Strecker K, et al. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure,comparison with B-type natriuretic peptide[J]. J Am Coll Cardiol, 2005, 46(6):1011-1018.
[13]宋浩明,罗明,邓兵. 不同剂量培多普利对慢性心力衰竭患者血浆ET和NO水平的影响[J]. 心脏杂志, 2005, 17(1):46-48.
[14]Duffy D, Rader DJ. Drugs in development targeting high-density lipoprotein metabolism and reverse cholesterol transport[J]. Curr Opin Cardiol, 2005, 20(4):301-306.
[15]王静,吴时达. 中药对血管内皮的保护作用[J]. 中国动脉硬化杂志, 2005, 13(1):116-118.
[16]杨富国,董果雄,张社华. 黄芪注射液对内皮细胞损伤的保护效应[J]. 青岛大学医学院学报, 2006, 42(3):250-253.
[17]吴琴琴,曾智. 褪黑素对受损血管内皮细胞的保护作用[J]. 心脏杂志, 2007, 19(1):99-101
[18]杨大春,周兴文,速晓华,等. 同型半胱氨酸对血管内皮细胞E-选择素、IL-6分泌的影响[J]. 心脏杂志, 2006, 18(1):57-59.